Bloomberg Senior ETF Analyst: Solana ETF may be approved by mid-March 2025 at the latest
Senior Bloomberg ETF analyst Eric Balchunas explained on social media platform X on Wednesday that it appears the final deadline for Solana ETF is mid-March 2025. But from now until then, the most important date is November. If Biden wins, these ETFs are likely to be phased out. If Trump wins, anything is possible.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like


BTC market cap briefly dropped out of the top 15 global assets

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit
An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.
